Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Leukemia 102Burkitt Lymphoma 50Lymphoma 49Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large B-Cell, Diffuse 21Leukemia, Lymphocytic, Chronic, B-Cell 21Leukemia, Biphenotypic, Acute 21Lymphoma, Non-Hodgkin 20Lymphoma, Follicular 17Recurrence 14Lymphoma, Mantle-Cell 14Lymphoma, B-Cell, Marginal Zone 13Lymphoma, Large-Cell, Immunoblastic 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large-Cell, Anaplastic 9Blast Crisis 8Multiple Myeloma 7Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Hodgkin Disease 6Neoplasm, Residual 5Myelodysplastic Syndromes 5Lymphoma, T-Cell 5Dendritic Cell Sarcoma, Interdigitating 5Leukemia, T-Cell 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, B-Cell 4Immunoblastic Lymphadenopathy 4Waldenstrom Macroglobulinemia 3

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1asparaginase erwinia chrysanthemi recombinant 1Vincristine 1Methotrexate 1Lenalidomide 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Cytarabine 1Calcium Dobesilate 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypersensitivity × Vincristine × Other hematologic neoplasm × Clear all
NCT00928200 2019-02-19

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Terminated
1 enrolled 7 charts
LymphoidOther hematologic neoplasm

Hypersensitivity, Leukemia, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡